Kisqali Plus Endocrine Therapy Improves Survival in Breast Cancer Subgroup
June 3rd 2019The addition of Kisqali to standard-of-care endocrine therapy significantly improved overall survival for premenopausal women with advanced HR-positive/HER2-negative breast cancer compared with endocrine therapy alone.
Read More
Specialized Care Is Needed for Adolescent and Young Adult Cancer Survivors
June 11th 2018The survey contained questions on a range of issues they may have experienced, including pain, fatigue, as well as issues with sexual function, body image and finances. Researchers then looked at the anxiety and depression associated with those issues, and talked with patients about what they thought might be causing those problems.
Read More
Investigational Drug Shows Promise in Patients with Metastatic Urothelial Cancer
June 5th 2018Enfortumab vedotin may be a potential novel therapy for patients with locally advanced or metastatic urothelial cancer, according to updated phase 1 study findings presented during the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
Read More
Broader Genetic Testing Can Save Costs, Determine Treatment Plans in Lung Cancer
June 1st 2018Using next-generation sequencing (NGS) to test patients with non-small cell lung cancer (NSCLC) for all known genetic mutations associated with the disease appeared to be faster and more cost-effective than testing for one gene at a time – not to mention the results could have treatment implications.
Read More
Genetic Counseling With Telemedicine Helps Patients in Community Practices
June 1st 2018Patients who would otherwise not have access to genetic counseling at community-based medical centers can benefit from the use of remote phone or video technology to take advantage of these services, according to study results presented at the American Society of Clinical Oncology Annual Meeting in Chicago on June 1-4.
Read More
Genetic Testing, Treatment Advances Offer 'Hope on the Horizon' for Ovarian Cancer
April 28th 2018During the 2018 National Ovarian Cancer Coalition, Angeles Alvarez Secord, M.D., MHSc highlighted the importance of genetic testing and its impact on treatment options for women with ovarian cancer.
Read More
Ovarian Cancer Expert Offers Hope Against 'Silent Killer' Stereotype
April 28th 2018CURE sat down with Richard Boulay, M.D., at the 2018 National Ovarian Cancer Coalition to discuss exciting updates in ovarian cancer, as well as what advice he would offer to patients and caregivers who may be feeling overwhelmed.
Read More